Adjunct Clinical Professor of Medicine, Stanford University; CEO, Cedar Associates
Internal Medicine
Dr. John C. Hornberger, MD
|
|
Give Review
John Hornberger works in the field of Internal Medicine. He researched medicine at University of Rochester School of Medicine and Dentistry. He received 8 awards: "Fellow", "Picker/Commonwealth Scholars Award", "Alpha Omega Alpha Honor Society", "The Medical Student Research Awards Program", "The Dean's Award for Distinction in Research", "Edward Henderson Memorial Student Award for Exceptional Initiative in and Dedication to the Field of Geriatrics, Second Award", "Best Scientific Presentation, Department of Pathology Annual Residents' Day" and "Phi Beta Kappa Honor Society". John C. Hornberger, MD is a published MD as well. He has 77 publications published. The latest was: Risks and costs of end-stage renal disease after heart transplantation.
Publications
- Cost Effectiveness Analysis of a Multivariate Index Assay compared to Modified ACOG Criteria and CA-125 in the Triage of Women with Adnexal Masses.
- Effect of a genomic classifier test on clinical practice decisions for patients with high-risk prostate cancer after surgery.
- Outcome and economic implications of proteomic test-guided second- or third-line treatment for advanced non-small cell lung cancer: Extended analysis of the PROSE trial.
- The clinical and economic implications of specimen provenance complications in diagnostic prostate biopsies.
- Proliferative epithelial disease identified in nipple aspirate fluid and risk of developing breast cancer: A systematic review.
- Health Care Coverage Decision Making in Low- and Middle-Income Countries: Experiences from 25 Coverage Schemes.
- Comparative Economics of a 12-Gene Assay for Predicting Risk of Recurrence in Stage II Colon Cancer.
- Influence of a genomic classifier on post-operative treatment decisions in high-risk prostate cancer patients: results from the PRO-ACT study.
- Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy.
- The social and economic burden of treatment-resistant schizophrenia: a systematic literature review.
- Cost-effectiveness of gene-expression profiling for tumor-site origin.
- Clinical Validity/Utility, Change in Practice Patterns, and Economic Implications of Risk Stratifiers to Predict Outcomes for Early-Stage Breast Cancer: A Systematic R...
- Cost-effectiveness of rituximab as maintenance therapy in patients with follicular non-Hodgkin lymphoma after responding to first-line rituximab plus chemotherapy.
- Laboratory-Developed Test-SynFRAME: An Approach for Assessing Laboratory-Developed Tests Synthesized from Prior Appraisal Frameworks.
- Cost utility in the United States of rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone for the treatment of elderly patients with diffuse large...
- Designing a cost-effective clinical trial.
- Eliminating language barriers for non-English-speaking patients.
- Computer-assisted quality of life assessment for clinical trials.
- Mortality, hospital admissions, and medical costs of end-stage renal disease in the United States and Manitoba, Canada.
- Cost-effectiveness of repeat medical procedures: kidney transplantation as an example.
- Ethical decision making and patient autonomy: a comparison of physicians and patients in Japan and the United States.
- The sample size for a clinical trial: a Bayesian-decision theoretic approach.
- Bridging language and cultural barriers between physicians and patients.
- Risks and costs of end-stage renal disease after heart transplantation.
- Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
- A systematic review of cost-utility analyses in HIV/AIDS: implications for public policy.
- The importance of sputum cytology in the diagnosis of lung cancer: a cost-effectiveness analysis.
- Patient preferences in coronary revascularization.
- A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.
- Deciding eligibility for transplantation when a donor kidney becomes available.
- Variation among quality-of-life surveys. Theory and practice.
- Cost-effectiveness of enfuvirtide for treatment-experienced patients with HIV in Italy.
- The cost-benefit of a randomized trial to a health care organization.
- A cost-benefit analysis of a cardiovascular disease prevention trial, using folate supplementation as an example.
- Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.
- Cost-effectiveness of enfuvirtide in HIV therapy for treatment-experienced patients in the United States.
- The effect of a patient's risk-taking attitude on the cost effectiveness of testing strategies in the evaluation of pulmonary lesions.
- When to base clinical policies on observational versus randomized trial data.
- Cost-effectiveness analysis of rituximab combined with chop for treatment of diffuse large B-cell lymphoma.
- Cost-effectiveness of rituximab (MabThera) in diffuse large B-cell lymphoma in The Netherlands.
- Effects of a self-administered previsit questionnaire to enhance awareness of patients' concerns in primary care.
- The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase.
- Incidence and cost of steroid side effects after renal transplantation.
- Clinical decision-support systems: evaluating the evaluation.
- Economic evaluation of rituximab plus cyclophosphamide, vincristine and prednisolone for advanced follicular lymphoma.
- Comprehensive evaluations of health care interventions: the realism-transparency tradeoff.
- Clustering and the design of preference-assessment surveys in healthcare.
- On the dilemma of preemptive kidney transplantation.
- Relationship between antiretroviral prescribing patterns and treatment guidelines in treatment-naive HIV-1-infected US veterans (1992-2004).
- Capecitabine plus docetaxel combination therapy.
- Introduction to Bayesian reasoning.
- The cost-effectiveness of bortezomib in relapsed/refractory multiple myeloma: Swedish perspective.
- The cost-effectiveness of treating women with a cervical vaginal smear diagnosis of atypical squamous cells of undetermined significance.
- Rechargeable spinal cord stimulation versus non-rechargeable system for patients with failed back surgery syndrome: a cost-consequences analysis.
- Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies.
- Incidence and long-term cost of steroid-related side effects after renal transplantation.
- Cost-effectiveness of adding rituximab to fludarabine and cyclophosphamide for the treatment of previously untreated chronic lymphocytic leukemia.
- Economic analysis of targeting chemotherapy using a 21-gene RT-PCR assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer.
- Economic implications of 21-gene breast cancer risk assay from the perspective of an Israeli-managed health-care organization.
- Principles of good practice for decision analytic modeling in health-care evaluation: report of the ISPOR Task Force on Good Research Practices--Modeling Studies.
- Pharmacoeconomics of folic acid supplementation for cardiovascular disease prevention.
- Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients.
- US insurance program's experience with a multigene assay for early-stage breast cancer.
- Effect of intradialytic parenteral nutrition on delivered Kt/V.
- The economic impact of psychotherapy: a review.
- Evaluating the consequences of multidisciplinary case management for patients with chronic renal failure.
- Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor-positive, lymph-node-negative early-stage breast cancer in Japan.
- A multivariate analysis of mortality and hospital admissions with high-flux dialysis.
- Variability among methods to assess patients'' well-being and consequent effect on a cost-effectiveness analysis.
- Prostate-specific antigen is not excreted by human kidney or eliminated by routine hemodialysis.
- Stability of numbers but not size of mouse forebrain cholinergic neurons to 53 months.
- A quantitative method of identifying older persons at risk for increasing long term care services.
- Minimum data needed on patient preferences for accurate, efficient medical decision making.
- The hemodialysis prescription and quality-adjusted life expectancy. Renal Physicians Association Working Committee on Clinical Guidelines.
- The hemodialysis prescription and cost effectiveness. Renal Physicians Association Working Committee on Clinical Guidelines.
- Is high-flux dialysis cost-effective?
Schools
University of Nebraska College of Medicine
University Of Rochester
Stanford University
Doctors Specialties
- Internal Medicine
Accepted Insurances
Awards
- Fellow
- Picker/Commonwealth Scholars Award
- Alpha Omega Alpha Honor Society
- The Medical Student Research Awards Program
- The Dean's Award for Distinction in Research
- Edward Henderson Memorial Student Award for Exceptional Initiative in and Dedication to the Field of Geriatrics, Second Award
- Best Scientific Presentation, Department of Pathology Annual Residents' Day
- Phi Beta Kappa Honor Society
Education
-
Stanford University -
University of Rochester School of Medicine and Dentistry
Helpful Reviews
Similar Doctors
|
|
Dr. Padmavathi Sainath, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Craig J. Hoffman, MD |
|
|
Dr. Ashu Goyal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carter W. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pavlina Apte, MD |
|
|
Dr. Sangita N. Shah, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khroshed Madan, MD |
|
|
Dr. Julie Wu, MD |
|
|
Dr. Tong S. Kobilka, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Kristin B. Gershfield, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Manavalan, MD
This Doctor is OpenDoctor Recommended.
|